Page 37 - Libertrim Alfa Literatura
P. 37

REFERENCIAS BIBLIOGRÁFICAS


            1.  Delgado-Quiñones EG, Cervantes-Sánchez P, Hernández-Calderón J, Ramírez-Ramos JK. Síndrome de
                intestino irritable, un padecimiento con enfoque integral. Rev Med MD. 2015;6(4):300-306.

            2.  Carmona-Sanchez R, Icaza-Chávez ME, Bielsa-Fernández MV, et al. Consenso mexicano sobre síndrome
                de intestino irritable. Revista de Gastroenterología de México. 2006;81(3):149-167.
            3.  Gasbarrini A, Lauritano EC, Garcovich M, et al. New insights into the pathophysiology of IBS: intestinal
                microflora, gas production and gut motility. European Review for medical and Pharmacologycal Sciences.
                2008;12(1):111-117.

            4.  Mearin Manrique F. Síndrome de Intestino Irritable. Sección III. Capítulo 14.

            5.  Spiller R, Aziz Q, Creed F, et al. Clinical Services Committee of The British Society of Gastroenterology.
                Gut. 2007;56(12):1770-1798.

            6.  Hotoleanu C, Popp R, Trifa AP,  et al. Genetic determination of irritable bowel syndrome.  World J
                Gastroenterol. 2008;14(43):6636-6640.

            7.  Kellow JE, Phillips SF, Miller LJ, Zinsmeister AR. Dysmotility of the small intestine in irritable bowel
                syndrome. Gut. 1988;29(9):1236-1243.
            8.  Simrén M, Castedal M, Svedlund J, et al. Abnormal propagation pattern of duodenal pressure waves in
                the irritable bowel syndrome (IBS) [correction of (IBD)]. Dig Dis Sci. 2000;45(11):2151-2161.

            9.  Kumar D,  Wingate DL. The irritable bowel syndrome: a paroxysmal motor disorder.  Lancet.
                1985;2(8462):973-977.

            10. Mayer EA, Naliboff BD, Chang L, Coutinho SV. V. Stress and irritable bowel syndrome. Am J Physiol
                Gastrointest Liver Physiol. 2001;280(4):G519-G524.
            11. Whitehead WE, Crowell MD, Robinson JC, et al. Effects of stressful life events on bowel symptoms:
                subjects with irritable bowel syndrome compared with subjects without bowel dysfunction.  Gut.
                1992;33(6):825-830.

            12. Parry SD, Stansfield R, Jelley D, et al. Is irritable bowel syndrome more common in patients presenting with
                bacterial gastroenteritis? A community-based, case-control study. Am J Gastroenterol. 2003;98(2):327-
                331.

            13. Hillilä M, Färkkilä MA, Sipponen T, et al. Does oral α-galactosidase relieve irritable bowel symptoms?
                Scand J Gastroenterol. 2016;51(1):16-21.

            14. Parker TJ, Naylor SJ, Riordan AM, Hunter JO. Management of patients with food intolerance in irritable
                bowel syndrome: the development and use of an exclusion diet. J Hum Nutr Diet. 1995;8(3):159-166.

            15. Hammerle CW, Surawicz CM. Updates on treatment of irritable bowel syndrome. World J Gastroenterol.
                2008;14(17):2639-2649.
            16. Libertrim® Alfa. Información para prescribir amplia. Carnot Laboratorios.







         LIBERTRIM® ALFA                                     37
   32   33   34   35   36   37   38   39   40